Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q3 FY23 results · Oct–Dec 2022
Bajaj Healthcare reported revenue from operations of ₹141.88 crore (down 15.3% from Q3 FY22) and net profit of ₹11.05 crore (down 36.6% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a standalone basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 141.88 | 167.57 | −15.3% | 200.89 | −29.4% |
| Other income | 0.07 | 0.20 | −63.6% | 0.13 | −45.2% |
| Total income | 141.96 | 167.77 | −15.4% | 201.03 | −29.4% |
| Profit before tax | 15.04 | 23.33 | −35.5% | 22.02 | −31.7% |
| Net profit for the period | 11.05 | 17.45 | −36.6% | 16.36 | −32.4% |
| EPS, basic (₹) | 4.01 | 6.32 | −36.6% | 5.93 | −32.4% |
| Net margin (%) | 7.8 | 10.4 | 8.1 |
Standalone
- Filed with BSE
- 16 Feb 2023, 16:58 IST
- Board meeting
- 13 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE